Tag Archives: CMS

Drug Reimbursement: Make Room at the Table for Patients and Researchers

At last week’s Partnering for Cures conference held in New York City, several expert panels discussed new angles of approaching solutions to disease, encouraging investment and mitigating inefficiencies in the delivery of medicines within the current healthcare system. A highlight was a session on  “Reimbursement: Can Value Drive Innovation?,” which looked at  defining value in […]
Posted in Events, FDA, healthcare, Market Access, pricing | Also tagged , , , , , , , , , , , , , , , | Leave a comment

Putting a Price Tag on Compliance: Cheap Change or Big Bucks?

Compliance rules under the US Physician Payments Sunshine Act have been criticized for the excruciating level of detail demanded from individual company submissions.  But relatively little scrutiny has been accorded to another pressing question:  how much will all this new reporting cost?  The burden of compliance for not just this new law but in many […]
Posted in compliance, Marketing, Regulatory, Strategy | Also tagged , , , , | 1 Comment

Co-Pay Offset Programs and the New Health Insurance Marketplace: Will the Feds Say No?

By Mark McAndrew. As the health insurance marketplaces begin enrollment this week and go live on January 1, 2014, several issues continue to be a source of significant confusion to manufacturers, payers and the millions of consumers purchasing health insurance for the first time through an exchange.  Many of these issues, such as the cost […]
Posted in Guest Blog, healthcare, Op-Ed, Regulatory | Also tagged , , , , , , , , | Leave a comment

The First Day of Obamacare: Is US Pharma Ready?

by Tom Norton For more than three years, the US pharmaceutical industry has known that today would arrive. So this is it. The first day that eligible U.S. citizens can sign up for Obamacare — and enjoy the prospect of prescription drug insurance, effective January 1st, 2014. I have spent the last week surveying many […]
Posted in Guest Blog, healthcare, Legal, Market Access, pricing, R&D, Regulatory, Sales, Strategy | Also tagged , , , , , , , | 1 Comment

Co-Pay Offset Programs and Health Insurance Marketplaces: Causes for Concern

Co-Pay Offset Programs and Health Insurance Marketplaces As the health insurance marketplaces begin enrollment next week and go-live on January 1, 2014, several issues continue to be a source of significant confusion to manufacturers, payers and millions of consumers who will be purchasing health insurance for the first time through an exchange.  Many of these […]
Posted in Guest Blog, healthcare, Op-Ed | Also tagged , , , , , , , | Leave a comment
  • Categories

  • Meta